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Abstract
Objective: To explore the expression of Glycogen synthase kinase 3 beta (GSK-3b) in renal allograft tissue and its
significance in the pathogenesis of chronic allograft dysfunction.
Methods: Renal allograft biopsy was performed in all of the renal allograft recipients with proteinuria or increased
serum creatinine level who came into our hospital from January 2007 to December 2009. Among them 28 cases
was diagnosed as chronic allograft dysfunction based on pahtological observation, including 21 males with a mean
age of 45 ± 10 years old and 7 females with a mean age of 42 ± 9 years old. The time from kidney transplantation
to biopsy were 1-9 (3.5) years. Their serum creatinine level were 206 ± 122 umol/L. Immunohistochemical assay
and computer-assisted genuine color image analysis system (imagepro-plus 6.0) were used to detect the
expression of GSK-3b in the renal allografts of 28 cases of recipients with chronic allograft dysfunction. Mean area
and mean integrated optical density of GSK-3b expression were calculated. The relationship between expression
level of GSK-3b and either the grade of inflammatory cell infiltration or interstitial fibrosis/tubular atrophy in renal
allograft was analyzed. Five specimens of healthy renal tissue were used as controls.
Results: The expression level of the GSK-3b was significantly increased in the renal allograft tissue of recipients
with chronic allograft dysfunction, compared to normal renal tissues, and GSK-3b expression became stronger
along with the increasing of the grade of either inflammatory cell infiltration or interstitial fibrosis/tubular atrophy
in renal allograft tissue.
Conclusion: There might be a positive correlation between either inflammatory cell infiltration or interstitial
fibrosis/tubular atrophy and high GSK-3b expression in renal allograft tissue.
Virtual slides: The virtual slide(s) for this article can be found here:
http://www.diagnosticpathology.diagnomx.eu/vs/9924478946162998.
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Introduction
Kidney transplantation is the optimal renal replacement
therapy for the patients with end stage renal disease
(ESRD). As the application of more new effective immu-
nodepressants and the development of transplant techni-
que, the incidence of acute rejection is obviously
decreasing in the early stage post transplantation, but the
long term survival of renal allografts is still a challenge of
clinical medicine. Recent researches have found that
chronic renal allograft dysfunction is the main factor
influence on the long term survival of renal allograft. The
main clinical manifestations of chronic renal allograft
dysfunction are serum level of creatinine is slowly creep-
ing upward company with proteinuria and hypertension,
and progression into ESRD need kidney transplantation
again or on maintenance dialysis. The main pathogenic
course of chronic renal allograft dysfunction is glomeru-
losclerosis, vasculopathy, atrophy of tubule and chronic
renal interstitial fibrosis. All the pathogenic changes are
associated with lymphocyte, plasmocyte and mastocyte
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any medium, provided the original work is properly cited.infiltration in the renal tissue. Researches have proved
that chronic inflammatory was the key pathogenic course
of nephron loss in various of kidney disease, including
chronic renal allograft dysfunction. Recently, researches
discovered that GSK-3b mediated chronic inflammatory
related to deterioration of renal allograft function, but
the mechanism has not been fully interpreted. In this
study, we mainly detected the expression of GSK-3b in
the tissue of renal allograft, and analyzed the relationship
between the expression of GSK-3b and inflammatory cell
infiltration in renal interstitium, interstitial fibrosis and




The renal biopsy samples were collected from kidney
transplant patients with proteinuria and elevated serum
creatine from January, 2007 to December 2009 in Guilin
No.181 hospital. In the 28 cases consistented with clinical
diagnosis of chronic allograft dysfunction, 21 cases were
males (age 45 ± 10 years) and 7 cases were females (age 42
± 9 years). The durations after kidney transplantation were
1~9 years (mean 3.5 years) and the mean levels of serum
creatine were 206 ± 122 μmol/L. The triple immunosup-
pressant protocols were cyclosporine + mycophenolate
mofetil + prednisone in 18 patients and tacrolimus +
mycophenolate mofetil + prednisone in 9 patients and sir-
olimus +.mycophenolate mofetil + prednisone in 1 patient.
Before renal biopsy, color Doppler supersonic detection in
renal allograft and serum drug levels were performed to
exclude acute rejection, nephrotoxicity of immunosup-
pressant, obstruction/backstreaming of ureter, thrombosis
or embolism in renal arteries or veins and other diseases.
The donors and recipients were matching in ABO blood
type, and two or more matching in HLA, and the results
of lymphocytotoxicity test were less than 10%, and the
results of panel reaction antibody (PRA) were negative.
The renal samples of 5 cases of control were collected
from routine donor renal biopsy before transplantation,
and the pathologic manifestation of which was normal.
Informed consents were obtained from all patients that
participated to the study. This study was performed under
the supervision of Institutional Review Board of Southern
Medical University, and abided the Helsinki Declaration
on ethical principles for medical research involving human
subjects.
Histological examination
The paraffin-embedded kidney sections were incised
into 3-μm-thick tissue sections that were deparafinized
through xylene and hydrated through graded ethanol
(100%, 96%, 90%, and 70%) and distilled water. The sec-
tions were stained by standard histology procedures,
including hematoxylin/feosin stain, periodic-acid schiff
(PAS) stain, masson trichrome and periodic schiff-
methenamine (PASM) stain. The slices were observed
under microscope in a blind manner, including inflam-
matory cell infiltration in renal tissues, increased mesan-
gial matrix and extracellular matric, proliferation of
mesangial cells, epithelium and endothelium, adhesions
and sclerosis, thickening of glomerular basement mem-
branes and double track sign; thickening of peritubular
capillaries basement membrane, interstitial fibrosis,
inflammatory cell infiltration, tubular atrophy and inti-
mal thickening of artery.
Pathologic diagnosis
Diagnosis criteria of chronic allograft dysfunction:
thickening and splitting appearance of glomerular base-
ment membrane, thickening of basement membrane of
peritubular capillaries, and/or diffuse monocyte infiltra-
tion of mononuclearcell, interstitial fibrosis/diffuse tub-
ular atrophy, and/or thickening of artery intima,
excluding acute rejection, nephrotoxicity of immuno-
suppressant, obstruction/back- streaming of ureter and
other diseases.
The degree of inflammatory cell infiltration in tubuloin-
terstitial was described as mild, midrange and severe.
There were few and scatter inflammatory cell infiltration
in 10-25% of parenchyma was defined as mild; inflamma-
tory cell infiltration in 26-50% of parenchyma was defined
as midrange; inflammatory cell infiltration in > 50% of par-
enchyma was defined as serve [1].
Degree of interstitial ﬁbrosis and tubular atrophy: IF/
TA-I, as mild interstitial ﬁbrosis and tubular atrophy
(< 25% of cortical area); IF/TA-II, as moderate interstitial
ﬁbrosis and tubular atrophy (26-50% of cortical area);
IF/TA-III, as Severe interstitial ﬁbrosis and tubular atro-
phy/loss (> 50% of cortical area) [1].
Immunohistochemisty examination
Immunohistochemisty with EnVision was used to detect
the expression of GSK-3b p r o t e i ni nt h er e n a la l l o g r a f t
tissue. 3-μm-thick tissue sections were hydrated through
graded ethanol, and endogenous peroxidase was blocked
with 3% peroxide. GSK-3b was repaired with microwave
for 15 minute. We incubated primary antibody (rabbit
anti-human GSK polyclonal antibody, 1:100, Wuhan
Boster Biological Technology, Ltd) to detect GSK-3b at
overnight at 4°C. After washing with PBS, we incubated
the tissue sections with the second antibody (mice anti-
rabbit monoclonal antibody, Maixin Biological Technol-
ogy Development Co. Fujian) for 30 min at 37°C, and
then washing with PBS, DAB coloration and re-stained
with hematoxylin.
Immunohistochemisty test of IgG, IgA, IgM, Clq, C4c
and C4d were performed in the same way.
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Images were acquired using a Leica DMR-X microscope
coupled to a Leica DC500 digital camera (Leica, Wetzlar,
Germany), using the image analysis system Quantimet
Q550 (Leica Imaging Systems). Ten randomly selected
discontinuous fields (400 x) per kidney were evaluated,
including tubulointerstitial in renal cortex, medulla and
the conjunction region, (but not including glomulular
and vessels). More than 60 tubulars in each biopsy sec-
tion. The positive area was yellowly stained and Image-
Pro Plus software was used to quantify the integrated
optical density. The ratio of positive area to total tubu-
lointerstitial area (not including the area of tubular
lumina) presented the relative amount of the substance
expression in tubuloinstitial.
Statistic analysis
Results are expressed as means ± SD. Statistical analysis
was performed using SPSS 13.0 (SPSS, Chicago, IL).
Measurement data was analyzed with one way ANOVA,
and the relationship was analyzed with linear correlation
(Pearson). Statistic significance was set at P < 0.05 level.
Results
Histological manifestation
The main histological manifestation of renal allograft in
the 28 cases of chronic renal allograft dysfunction as:
interstitial fibrosis and tubular atrophy accompany with
infiltration of inflammatory cells including lymphocyte
and monocyte, enlarge of some tubular lumens, thicken-
ing of glomerular basement membrane as double trace
sign and focal segmental glomerulosclerosis, thickening
of artery intimae. Discrepancy to the presentation of
acute rejection, nephrotoxicity of immunosuppressant
and obstruction uropathy/reflux nephropathy.
The expression of GSK-3b in renal tissue
There was weak expression of GSK-3b in the cytoplasm
of tubular epithelia cell in normal renal tissue. However,
in the dysfunction renal allograft tissue, there were
strong cytoplasm GSK-3b expression in tubular epithelia
cell, and stronger expression in the patients with more
severity tubulointerstitial damage. (Shown in table 1,
table 2 and Figure 1, 2, 3, 4, Figure 5, 6, 7, 8).
The relationship of GSK-3b expression and
inflammatory infiltration, interstitial fibrosis and
tubularatrophy
In the renal tissue of chronic renal allograft dysfunction,
the integrated optical density (IOD) was higher than
normal renal tissue by analysis with Image-Pro software,
and the highest of IOD in more severity of inflamma-
tory infiltration, interstitial fibrosis and tubular atrophy
(Figure 9, 10).
Discussion
Renal allograft chronic dysfunction is the main factor
influence on the long term survival of renal allograft,
and is due to multiple causes. The clinical manifesta-
tions are gradually loss of renal allograft function and
serum creatinine slowly creeping upward. The risk fac-
tors of renal allograft dysfunction include immune fac-
tors, such as times of early acute rejection and matching
of HLA and protocol of immunosuppression, and non-
immune factors such as ischemia/reperfusion injury,
delayed graft function, nephrotoxicity of calcineurin
inhibitors, hypertension and dyslipidemia, and progres-
sively develop into end stage renal disease. Chronic
renal allograft dysfunction morphological appearance as
thickening of glomerular basement membrane as double
contours sign, thickening of the basement membrane of
p e r i t u b u l a rc a p i l l a r y ,a n d / o rd i f f u s em o n o n u c l e a rc e l l
infiltration and fibrosis in interstitium and difusse tubu-
lar atrophy, and/or thickening of artery intima.
Our study has found that GSK-3b was weakly
expressed in normal renal tissue, and was strongly
expressed in chronic dysfunction renal allograft tissue,
and was stronger in the more severity of pathological
changes. The IOD of GSK-3b was higher than that in
normal renal tissue, and increasing with the severity of
inflammatory infiltration, interstitial fibrosis and tubular
atrophy, which suggest that the correlation of GSK-3b
expression and interstitial inflammatory infiltration,
interstitial fibrosis/tubular atrophy. It was necessary to
further study the pathogenic mechanism of GSK-3b in
Table 1 The area and integrated optical density of
GSK-3b expression in renal tissue with different degree
of inflammatory infiltration
n Area of GSK expression(%) GSK(IOD)
Control Group 5 17.45 ± 19.63 21757 ± 23765
Mild Group 11 33.15 ± 9.16
⋇ 48331 ± 20335
⋇
Moderate Group 10 45.77 ± 14.56
⋇⋆ 70702 ± 24891
⋇⋆
Severe Group 7 60.83 ± 13.53
⋇⋆♦ 96300 ± 28169
⋇⋆♦
⋇: p < 0.05, vs Control Group;
⋆: p < 0.05, vs Mild Group;
♦: p < 0.05, vs
Moderate Group.
GSK: glycogen synthase kinase; IOD: integrated optical density.
Table 2 The area and integrated optical density of
GSK-3b expression in renal tissue with different degree
of interstitial fibrosis and tubular atrophy
n GSK(%) GSK(IOD)
Control group 5 17.45 ± 19.63 21757 ± 23765
IF/TA-I group 12 35.48 ± 11.90
⋇ 52017 ± 23216
⋇
IF/TA-II group 11 48.50 ± 16.51
⋇⋆ 741235 ± 26216
⋇
IF/TA-III group 5 57.80 ± 14.40
⋇⋆ 94615 ± 33855
⋇⋆
⋇: p < 0.05, vs Control Group;
⋆: p < 0.05, vs IF/TA-I Group;
♦: p < 0.05, vs IF/
TA-II Group.
GSK: glycogen synthase kinase; IOD: integrated optical density.
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stitial fibrosis and tubular atrophy.
Recent researches have found that the GSK-3b family
of serine/threonine kinases extensively existed in the
eucaryon, and mainly express in the lung, kidney and
brain, and influence on construction, growth, activation
and apoptosis of the cells by involving the basic cellular
processes such as signal transduction, regulation of insu-
lin, gene transcription and translation. The activation of
GSK-3b mainly through phosphorylation of serine-9 near
the N-terminus, and is associated to the regulation of sig-
nal pathway of Wnt, protein kinase B/Akt and NF-B.
The abnormal activatin of GSK-3b is associated with sev-
eral kidney diseases, such as diabetic nephropathy,
mesangioproliferative glomerulonephritis, lupus nephritis
and chronic allograft nephropathy. Recently, several
researches revealed that GSK-3b involved in human
inflammatory diseases by controling the production of
inflammatory factors and involvement into NF-Bs i g n a l
pathway, and the activation of NF-B is the center step
of inflammatory reaction. Giannopoulou M. et al. found
in cultured renal tubular epithelium that hepatocyte
growth factor (HGF) has a potent suppressive effect on
NFkappaB activation, which was mediated by GSK-3b.
HGF can inhibit renal inflammation and proinflamma-
tory chemokine expression by disrupting NF-kB signaling
[2]. Adminis- tration of a GSK-3 inhibitor potently sup-
pressed the proinflammatory response in mice receiving
lipopolysaccharide and mediated protection from endo-
toxin shock [3]. Study of Gong and colleagues had proved
that GSK-3b was a new marker of chronic renal allograft
dysfunction and mediating proinflammatory NF-kB acti-
vation and renal inflammation. GSK-3b over expression
Figure 1 GSK-3b expression in renal tissue with different
degree of inflammatory infiltration: control group.
Figure 2 GSK-3b expression in renal tissue with different
degree of inflammatory infiltration: mild degree of inflammatory
infiltration.
Figure 3 GSK-3b expression in renal tissue with different
degree of inflammatory infiltration: moderate inflammatory
infiltration.
Figure 4 GSK-3b expression in renal tissue with different
degree of inflammatory infiltration: severe inflammatory
infiltration.
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of GSK-3b phosphorylation (p-GSK, inactivation state)
was inversely correlated with the degree of injury as
assessed by Banff criteria. The higher level of p-GSK
expression, the lower level of tubular atrophy and inter-
stitial fibrosis [4].
Chronic renal allograft dysfunction is an important
factor influence on the long term survival of transplant
kidney, but the pathogenic mechanism is still not fully
interpreted. Infiltration of mononuclear cell (monocyte
and lymphocyte) often presents in the renal tissue of
chronic dysfunction and relate to endarteritis and inter-
stitial fibrosis. Impairment of renal tubular epithelium
and interstitial inflammatory infiltration play an impor-
tant role in various kidney diseases. Inflammatory fac-
tors induce secretion of extracellular matrix by
interstitial fibrocyte and result in interstitial fibrosis. In
vitro and in vivo experiments shown that GSK-3b
involved in inflammatory diseases and inhibition of
GSK-3b retarded the progression of these diseases. In
the diabetic nephropathy mice experiment model, trogli-
tazone a peroxisome proliferator -activated receptor
gamma (PPAR gamma) agonists, ameliorate renal fibro-
tic lesions through reverse high glucose induced expres-
sions of GSK-3b and inhibition epithelial-mesenchymal
transition [5]. In the rats with experimental mesangial
proliferative glomerulonephritis, inhibitors of cyclin-
dependent kinase (CDK)/GSK-3b were the effective
antagonists of proliferating and immunity renal disease
[6]. CDK/GSK-3b inhibitors suppress pathogenic prolif-
eration, apoptosis, and inflammation, and promote
regeneration of injured tissue in parenchymal renal dis-
eases [7]. Sinha D and his colleague had studied the
proximal tubular cells cultured in the absence of growth
Figure 5 GSK-3b expressions in renal tissue with different
degree of interstitial fibrosis/tubular atrophy: control group.
Figure 6 GSK -3b expressions in renal tissue with different
degree of interstitial fibrosis/tubular atrophy: IF/TA-I Group.
Figure 7 GSK -3b expressions in renal tissue with different
degree of interstitial fibrosis/tubular atrophy: IF/TA-II Group.
Figure 8 GSK -3b expressions in renal tissue with different
degree of interstitial fibrosis/tubular atrophy: IF/TA-III Group.
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survival of proximal tubular cells. The main mechanism
was by activation of Wnt signaling, which promoted the
repair of damaged renal parenchyma [8].
Summary, there is intensive expression of GSK-3b in
the renal tissue of the patients with chronic allograft
dysfunction, and is associated with inflammatory cell
infiltration of interstitium and interstitial fibrosis/tubular
atrophy. Further studies are needed to investigate the
pathogenic mechanism of GSK-3b expression in the
renal tissue of chronic allograft dysfunction. Inhibition
the activity of GSK-3b may be a new treatment target of
prevention chronic renal allograft dysfunction.
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